These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 22190448)

  • 1. Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma.
    Venkatramani R; Wang L; Malvar J; Dias D; Sposto R; Malogolowkin MH; Mascarenhas L
    Pediatr Blood Cancer; 2012 Sep; 59(3):493-8. PubMed ID: 22190448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
    Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
    J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of serum alpha-fetoprotein response during treatment of hepatoblastoma.
    Koh KN; Park M; Kim BE; Bae KW; Kim KM; Im HJ; Seo JJ
    Pediatr Blood Cancer; 2011 Oct; 57(4):554-60. PubMed ID: 21370433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the HB-89 Study in treatment of malignant epithelial liver tumors in childhood and concept of a new HB-94 protocol].
    von Schweinitz D; Bürger D; Bode U; Weinel P; Erttmann R; Hecker H; Mildenberger H
    Klin Padiatr; 1994; 206(4):282-8. PubMed ID: 7526028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
    Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
    J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma.
    Meyers RL; Katzenstein HM; Krailo M; McGahren ED; Malogolowkin MH
    J Pediatr Surg; 2007 Dec; 42(12):2050-6. PubMed ID: 18082706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features predicting unresectability in hepatoblastoma.
    D'Antiga L; Vallortigara F; Cillo U; Talenti E; Rugge M; Zancan L; Dall'Igna P; De Salvo GL; Perilongo G
    Cancer; 2007 Sep; 110(5):1050-8. PubMed ID: 17661341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study.
    Wang LL; Filippi RZ; Zurakowski D; Archibald T; Vargas SO; Voss SD; Shamberger RC; Davies K; Kozakewich H; Perez-Atayde AR
    Am J Surg Pathol; 2010 Mar; 34(3):287-99. PubMed ID: 20118773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of unfavorable hepatoblastoma in children of very low birth weight: results of a surgical and pathologic review.
    Ikeda H; Hachitanda Y; Tanimura M; Maruyama K; Koizumi T; Tsuchida Y
    Cancer; 1998 May; 82(9):1789-96. PubMed ID: 9576303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
    Heifetz SA; French M; Correa M; Grosfeld JL
    Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-agent cisplatin treatment of children with high-risk hepatoblastoma.
    Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
    J Pediatr Hematol Oncol; 2014 May; 36(4):271-5. PubMed ID: 24309602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is multifocality a prognostic factor in childhood hepatoblastoma?
    Saettini F; Conter V; Provenzi M; Rota M; Giraldi E; Foglia C; Cavalleri L; D'Antiga L
    Pediatr Blood Cancer; 2014 Sep; 61(9):1593-7. PubMed ID: 24757164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
    Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
    Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical strategies for unresectable hepatoblastomas.
    Tajiri T; Kimura O; Fumino S; Furukawa T; Iehara T; Souzaki R; Kinoshita Y; Koga Y; Suminoe A; Hara T; Kohashi K; Oda Y; Hishiki T; Hosoi H; Hiyama E; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2194-8. PubMed ID: 23217875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma.
    Venkatramani R; Stein JE; Sapra A; Genyk Y; Jhaveri V; Malogolowkin M; Mascarenhas L
    Br J Surg; 2015 Jan; 102(1):108-13. PubMed ID: 25349947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.